BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/21/2015 1:59:00 PM | Browse: 1067 | Download: 1310
Publication Name World Journal of Clinical Cases
Manuscript ID 14334
Country/Territory
Received
2014-09-29 08:39
Peer-Review Started
2014-09-29 21:11
To Make the First Decision
2014-12-17 11:24
Return for Revision
2014-12-19 13:42
Revised
2014-12-30 00:25
Second Decision
2015-06-12 08:21
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2015-06-19 17:17
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2015-08-08 16:23
Publish the Manuscript Online
2015-08-21 13:58
ISSN 2307-8960 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Urology & Nephrology
Manuscript Type Case Report
Article Title Rituximab therapy for primary glomerulonephritis: Report on two cases
Manuscript Source Unsolicited Manuscript
All Author List Fabrizio Fabrizi, Donata Cresseri, Giovanni B Fogazzi, Gabriella Moroni, Patrizia Passerini, Paul Martin and Piergiorgio Messa
Funding Agency and Grant Number
Corresponding Author Fabrizio Fabrizi, MD, Division of Nephrology, Maggiore Hospital, IRCCS Foundation, Pad. Croff, via Commenda 15, 20122 Milano, Italy. fabrizi@policlinico.mi.it
Key Words Chronic kidney disease; Cryoglobulinemic vasculitis; Membranoproliferative glomerulonephritis; Rituximab
Core Tip A small but growing body of evidence is emerging on the efficacy and safety of rituximab therapy for primary glomerulonephritis. Various authors have claimed that rituximab for glomerular diseases is effective and has minimal adverse effects. We report on two male Caucasian patients who were refractory to conventional immunosuppressive therapy; each of them received one rituximab pulse and developed sepsis over the follow-up, the first patient died two months after rituximab therapy. The risks (and the predictive factors) of severe infections in kidney patients on rituximab therapy are unclear and appear an area of active research.
Publish Date 2015-08-21 13:58
Citation Fabrizi F, Cresseri D, Fogazzi GB, Moroni G, Passerini P, Martin P, Messa P. Rituximab therapy for primary glomerulonephritis: Report on two cases. World J Clin Cases 2015; 3(8): 736-742
URL http://www.wjgnet.com/2307-8960/full/v3/i8/736.htm
DOI http://dx.doi.org/10.12998/wjcc.v3.i8.736
Full Article (PDF) WJCC-3-736.pdf
Full Article (Word) WJCC-3-736.doc
Manuscript File 14334-Review.doc
Answering Reviewers 14334-Answering reviewers.pdf
Audio Core Tip 14334-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 14334-Conflict-of-interest statement.pdf
Copyright License Agreement 14334-Copyright assignment.pdf
Institutional Review Board Approval Form or Document 14334-Institutional review board statement.pdf
Peer-review Report 14334-Peer-review(s).pdf
Scientific Misconduct Check 14334-Scientific misconduct check.pdf
Scientific Editor Work List 14334-Scientific editor work list.pdf